Investor Presentaiton
Strengthening the foundation and
improving profitability
Organic growth / expansion of site
Start-up of Ortigueira
sodium chlorate site (BR)
Bradford polymer
expansion (UK)
San Giorgio polymer
expansion (IT)
Acquisition
Chevron CEOR deal &
Botlek expansion
Start-up of Joutseno chlorate
expansion (FI)
Major oil sands tailings water
treatment deal (CA)
Operational efficiencies
Closure of site / divestment
AKD wax manufacturing
JV deal closed (CN)
Start-up of new AKD wax site
(CN)
Polymer investment decision,
Mobile (US)
Joint Venture - Dry polymers
(SK)
Ramp-up of of new AKD
wax site (CN)
Ramp-up of of Botlek
polymer facility (NL)
Eastover Bleaching
extension start-up (US)
2020
Operative
2019
Operative
EBITDA
2015: 12.1%
2016
Transportation agreement with
Odyssey
Botlek modernization (NL)
BOOST operational
excellence program launch
Closures of Ottawa (CA) and
Zaramillo (ES), coagulants
2017
Two segment
structure operational
Odyssey go-live
in North America
2018
'Value over volume' initiated
Odyssey go-live in Europe
Closing of ECOX detergent
production (SWE)
Move from 'Value over volume'
to 'Active price management'
Cost savings in Pulp & Paper
Divestment of coagulant
asset (IT)
Divestment of Kemira Operon
(water treatment facility
operations, FI)
EBITDA
2020: 17.9%
Chlorate and peroxide
expansion on-going in Fray
Bentos (UY)
-
Goole coagulant expansion (UK)
on-going
Raw material flexibility:
Coagulants to Magnetite
- Bradford AN purification
Kemira FEBRUARY 11, 2021 INVESTOR PRESENTATION
17View entire presentation